|The Rotavirus (all serotypes) n/a (Catalog #MBS316568) is an Antibody produced from Sheep and is intended for research purposes only. The product is available for immediate purchase. The Sheep anti Rotavirus reacts with Human and may cross-react with other species as described in the data sheet. MyBioSource\'s Rotavirus (all serotypes) can be used in a range of immunoassay formats including, but not limited to, Suitable for use in ELISA, Immunofluorescence and functional assays.
Each laboratory should determine and optimum working for use in its particular application. Other application have not been tested but use in such assays should not necessarily be excluded. Researchers should empirically determine the suitability of the Rotavirus (all serotypes) n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Immunogen: Five serotypes of group A Rotavirus strains: Wa (serotype I), DS-1 (serotype II), Ito (serotype III), HOCHI (serotype IV) and 69M (serotype VIII). Buffer: PBS
Preservative: 0.09% Sodium azide
Important Note: Centrifuge before opening to ensure complete recovery of vial contents.
Warnings: This product contains sodium azide, which has been classified as Xn (Harmful), in European Directive 67/548/EEC in the concentration range of 0.1 - 1.0%. When disposing of this reagent through lead or copper plumbing, flush with copious volumes of water to prevent azide build-up in drains. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing Rotavirus (all serotypes) are readily searchable from our website. Different antibodies against the same target such as Rotavirus (all serotypes) may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.